[CO2-laser therapy of stigmatizing cutaneous lesions in tuberous sclerosis (Bourneville-Pringle) and in neurofibromatosis 1 (von Recklinghausen)].

Abstract

Tuberous sclerosis (Bourneville-Pringle) and type I neurofibromatosis (von Recklinghausen) are familial multiple tumour syndromes. Both entities have in common that the cutaneous manifestations can stigmatize the carriers and considerably reduce the quality of life. CO2-laser surgery (vaporisation) consistently yields good to excellent aesthetic results in the treatment of adenoma sebaceum in tuberous sclerosis. Patients with type I neurofibromatosis who carry several hundreds neurofibromas usually benefit from a numerical reduction in their skin lesions, despite the less predictable aesthetic result, ranging from excellent to fair. The present study reports on the treatment outcome of CO2-laser surgery in 8 patients with adenoma sebaceum and 8 with neurofibromatosis.

• Authors: K Querings, D Fuchs, E E Küng, J Hafner
• Journal: Schweizerische medizinische Wochenschrift (Schweiz Med Wochenschr) Vol. 130 Issue 45 Pg. 1738-43 (Nov 11 2000) ISSN: 0036-7672 [Print] Switzerland
• Vernacular Title: CO2-Laser-Therapie stigmatisierender Hautveränderungen bei tuberöser Sklerose (Bourneville-Pringle) und bei Neurofibromatose Typ I (von Recklinghausen).
• PMID: 11109606 (Publication Type: English Abstract, Journal Article)

Topics

• Adolescent
• Adult
• Female
• Humans
• Laser Therapy
• Male
• Neurofibromatosis 1 (complications, surgery)
• Retrospective Studies
• Skin Diseases (surgery)
• Tuberous Sclerosis (complications, surgery)